Please Wait...

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Congress - Berlin, Germany

ECTRIMS Annual Congress
October 10, 2018 - 1:00am (EDT) to October 12, 2018 - 1:00am (EDT)

Berlin, Germany

Latest advances in artificial intelligence (AI) in multiple sclerosis (MS) segmentation. "Deep Learning-Based Automated MS T2 Lesion Segmentation." Bioclinica's Director of Neuroscience, Luc Bracoud, will present our latest image analysis developments applied to MS during the October 12th poster session at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Annual Congress in Berlin. View the ECTRIMS program for session details: P1138 - Deep-learning based automated MS T2 lesion segmentation, presented by Luc Bracoud, Director of Neuroscience, Bioclinica.

To learn about the application of AI in MS and other recent developments and how Bioclinica's domain experts can support your MS trials, submit a Contact Us form and we will direct your request to Luc Bracoud and Dr. Joyce Suhy.

Visit event website


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @MdFacep: FDA approvals: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer. BIG! @Reu…
Bioclinica (11 hours ago)
RT @FDA_Drug_Info: National Prescription Drug Take Back Day is April 27, 2019 from 10:00 AM to 2:00 PM. Learn how to dispose of unused and…
Bioclinica (11 hours ago)
RT @iofbonehealth: #Osteoporosis Int: Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international…
Bioclinica (11 hours ago)
RT @HINJ_ORG: New Jersey's biopharmaceutical industry: CIANJ has assembled a panel of industry leaders @Celgene, @Bayer & @PhRMA to discuss…
Bioclinica (11 hours ago)
RT @PhRMA: Last year, the top 15 largest biopharmaceutical companies spent more than $100 billion on R&D, according to @IQVIA_global. More…
Bioclinica (11 hours ago)
RT @SCDM_DataDriven: Registrations for the SCDM 2019 Annual Conference are now open!! #SCDM2019 Register now for the biggest event in the…
Bioclinica (11 hours ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box